Table 2.
Author | Refs | Study design | Study size | Function | Main result |
---|---|---|---|---|---|
Zhou | [128] | Bioinformatics tool | 533 KIRC samples | Genotyping prediction |
Highly expressed CLOCK, CRY1/2, PER2/3, and RORA had better OS Increased CLOCK, CRY1/2, PER1/2/3, and RORA enjoyed better DFS BMAL1, PER1/2, RORA, and NR1D1 were significantly upregulated but CLOCK and CRY1/2 were downregulated |
Qiu | [134] | Bioinformatics tool | 538 cases and 72 adjacent normal tissues | Genotyping prediction |
High levels of CLOCK, PER1/2/3, NR1D2, and RORA experienced longer OS Increased Timeless and NPAS2 levels indicated poor survival CLOCK, PER1/2/3, CRY2, NPAS2, NR1D2, and RORA were highly expressed in kidney cancer patients with TNM stage (I-II) PER1/2/3, CRY2, Timeless, NPAS2, NR1D2, and RORA were highly expressed in well differentiated carcinoma type (G1, G2) |